Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04093024
Recruitment Status : Recruiting
First Posted : September 17, 2019
Last Update Posted : September 13, 2021
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim